Keywords: آنتی ترومبین; aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI آنتی ترومبین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ترومبین; Endothelium; Syndecan-1; Hyaluronan; Antithrombin; Sepsis; Inflammation; Microcirculation;
Keywords: آنتی ترومبین; Thrombin generation assay; Antithrombin; Endothelial cells; Heparan sulphates;
Keywords: آنتی ترومبین; Anticoagulants; Antithrombin; Disseminated intravascular coagulation; Sepsis; Thrombomodulin;
Keywords: آنتی ترومبین; AT; antithrombin; HBS; heparin binding site; DVT; deep venous thrombosis; ETP; Endogenous thrombin potential; AUC; Area under curve; IQR; Interquartile Range; Hz; Heterozygous; Ho; Homozygous; PE; Pulmonary embolism; VTE; Venous thromboembolism; Antithrom
Keywords: آنتی ترومبین; hAT; human antithrombin; AT; antithrombin; DIC; disseminated intravascular coagulation; CHO; Chinese hamster ovary; SERPIN; serine protease inhibitor; Neu5Ac; N-acetylneuraminic acid; rhAT; recombinant hAT; BHK; baby hamster kidney; FUT8; α-1,6-fucosyltr
Keywords: آنتی ترومبین; Antithrombin; SERPINC1; Mutations; Thrombosis;
Keywords: آنتی ترومبین; A2Ms; α-2- macroglobulins; AFLEI; elastase inhibitor from Aspergillus flavus; AFUEI; elastase inhibitor from Aspergillus fumigatus; AP; α-2-antiplasmin; AT; antithrombin; bFGF; basic fibroblast growth factor; BSuPI; Bacillus subtilis protease inhibitor;
Keywords: آنتی ترومبین; antithrombin; anticoagulation; cardiopulmonary bypass; pediatrics; ACT; activated clotting time; heparin;
Keywords: آنتی ترومبین; Antithrombin; Recombinant antithrombin; Intensive care unit; Disseminated intravascular coagulation; Bleeding complication;
Keywords: آنتی ترومبین; Blood coagulation; Tissue factor; Thrombin; Platelets; Protease-activated receptors; Metastasis; AT; antithrombin; BMI; body mass index; CA-125; cancer antigen 125; CCC; clear cell carcinoma; CD; cluster of differentiation; CG; control group; DVT; deep ve
Keywords: آنتی ترومبین; Anticoagulation; Antithrombin; Kunitz-type; Pathophysiology; Phospholipase A2; Protease inhibitor; Snaclecs; Snake venom; Therapeutics;
Keywords: آنتی ترومبین; aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: آنتی ترومبین; Antithrombin; Bleeding; Disseminated intravascular coagulation; Sepsis; Thrombomodulin
Keywords: آنتی ترومبین; Antithrombin; Coagulation; Disseminated intravascular coagulation; High mobility group box protein; Histones; Protein C; Thrombomodulin; Von willebrand factor
Keywords: آنتی ترومبین; Early preeclampsia; Antithrombin; Proteinuria; D-dimer; Composite perinatal morbidity;
Keywords: آنتی ترومبین; MELD; Model for End-stage Liver Disease; vWF-Ag; von Willebrand factor antigen; PC; protein C; AT; antithrombin; FVIII; factor VIII; PH; portal hypertension; VB; variceal bleeding; AUC; area under the curve; von Willebrand factor antigen; Procoagulant imb
Keywords: آنتی ترومبین; Capillary electrophoresis-mass spectrometry; Antithrombin; Conformers; Latent form; Heterodimer; AT; antithrombin; BGE; background electrolyte; BPE; base peak electropherogram; CE; capillary electrophoresis; CE-MS; capillary electrophoresis-mass spectrome
Keywords: آنتی ترومبین; AT; antithrombin; BSA; bovine serum albumin; CTA; cetyltrimethylammonium; Gal; galactose; GlcA; glucuronic acid; LMWH; low-molecular-weight heparin; NMR; nuclear magnetic resonance; SAX; strong anion exchange; USP; United States Pharmacopeia; Enoxaparin s
Keywords: آنتی ترومبین; factor V Leiden mutation; hypercoagulable state; hyperhomocysteinemia; livedoid vasculopathy; protein C deficiency; protein S deficiency; thrombophilia; thrombosis; ulcers; warfarin necrosis; AB; atrophie blanche; APC; activated protein C; APS; antiphosph
Keywords: آنتی ترومبین; Angiogenesis; Endogenous antiangiogenic proteins; Antithrombin; Heparin; Serpin; Coagulation; Tumor growth;
Keywords: آنتی ترومبین; aPTT; Activated partial thromboplastin time; AT; Antithrombin; ATC; Antithrombin concentrate; TCH; Texas Children's Hospital; UFH; Unfractionated heparin;
Keywords: آنتی ترومبین; Anaemia; antithrombin; coagulopathy; heparin resistance; heparin-induced thrombocytopenia; massive transfusion
Keywords: آنتی ترومبین; AT; antithrombin; AUC; area under the curve; HGMD; Human Gene Mutation Database; HGVS; Human Genome Variation Society; NCBI; National Center for Biotechnology Information; NPV; negative predictive value; PPV; positive predictive value; Q2; accuracy; ROC;
Keywords: آنتی ترومبین; GAG; glycosaminoglycan; GlcA; d-glucuronic acid; GlcA2SO3; d-glucuronic acid 2-sulfate; GlcN; d-glucosamine; GlcNSO36SO3; d-glucosamine N,6-sulfated; IdoA; l-iduronic acid; IdoA2SO3; l-iduronic acid 2-sulfate; TSD; trisulfated disaccharide; AT; antithromb
Keywords: آنتی ترومبین; Antithrombin; Protein C; Protein S; Venous thromboembolism;
Keywords: آنتی ترومبین; Antithrombin; Pregnancy; Postpartum;
Keywords: آنتی ترومبین; Antithrombin; Mutation analysis; Risk assessment;
Keywords: آنتی ترومبین; Albumin; Antithrombin; Gestational hypertension; Obstetric disseminated intravascular coagulation; Preeclampsia;
Keywords: آنتی ترومبین; AT; antithrombin; VTE; venous thromboembolism; Ox; Oxyuranus scutellatus; ELISA; enzyme-linked immunosorbent assay; APC; activated protein C; TGA; thrombin generation assay; PT-INR; prothrombin time-international normalized ratios; SD; standard deviation;
Keywords: آنتی ترومبین; Antithrombin; Newborn foal; Sepsis; Septic shock;
Keywords: آنتی ترومبین; Heparin; Heparan sulfate; Hemorrhagic activity; Antithrombin; Anticoagulant; Thermostabilization;
Keywords: آنتی ترومبین; CPB; cardiopulmonary bypass; TG; thrombin generation; CAT; calibrated automated thrombography; TFPI; tissue factor pathway inhibitor; AT; antithrombin; CABG; coronary artery bypass grafting; ACT; activated clotting time; UFH; unfractionated heparin; PPP;
Keywords: آنتی ترومبین; ADR; adverse drug reaction; AE; adverse event; AML; acute myeloid leukemia; ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; APTT; activated partial thromboplastin time; AT; antithrombin; CLL; chronic lymphocytic leukemia; CML; chroni
Keywords: آنتی ترومبین; AT; antithrombin; OHSS; ovarian hyperstimulation syndrome; HCG; human chorionic gonadotropin; IVF; in-vitro fertilization; RAS; renin-angiotensin system; VEGF; vascular endothelial growth factor; vW; von Willebrand; VTE; venous thromboembolism; PIATD; pre
Keywords: آنتی ترومبین; AT; antithrombin; ETP; endogenous thrombin potential; PC; protein C; PH; portal hypertension; PS; protein S; PT; prothrombin time; PVT; portal vein thrombosis; TIPS; transjugular intrahepatic portosystemic shunt; Portal vein thrombosis; Liver cirrhosis; C
Keywords: آنتی ترومبین; Affinity capillary electrophoresis; Heparin; Antithrombin; Binding constant; In-vitro activity; Saccharide composition;
Keywords: آنتی ترومبین; AT; Antithrombin; serpin; Serine protease inhibitor; FXa; Factor Xa; RCL; Reactive center loop; Arg; Arginine; Lys; Lysine; VTE; Venous thromboembolism; type II RS; Type II reactive site defects; type II HBS; Type II heparin binding site defects; type II
Keywords: آنتی ترومبین; 25; 41.1; AE; adverse event; AT; antithrombin; CPB; cardiopulmonary bypass; HR; heparin reistance; ICU; intensive care unit; SAE; serious adverse event;
Keywords: آنتی ترومبین; AT; antithrombin; AZ; AstraZeneca; CAT; calibrated automated thrombogram; ETP; endogenous thrombin potential; LT; lag time; HTS; high-throughput screening; PPP; platelet poor plasma; PRP; platelet rich plasma; RU; resonance units; SPR; surface plasmon res
Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms
Keywords: آنتی ترومبین; Antithrombin; α and β-AT; Genetic variants; Laboratory assays; Diagnostic strategy;
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate platelets
Keywords: آنتی ترومبین; eHUS; Escherichia coli-induced hemolytic uremic syndrome; Stx; Shiga toxin; EHEC; Enterohemorrhagic Escherichia coli; AT; antithrombin; AKI; acute kidney injury; t-PA antigen; tissue plasminogen activator antigen; PAI-1; t-PA-plasminogen activator inhibit
Antithrombotic potential of esculin 7, 3â², 4â², 5â², 6â²-O-pentasulfate (EPS) for its role in thrombus reduction using rat thrombosis model
Keywords: آنتی ترومبین; Anticoagulant; Serpin; Thrombosis; Antithrombin; Sulfated esculin;
Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT)
Keywords: آنتی ترومبین; HSCT; Hematopoietic Stem Cell Transplant; HE; hemorrhagic events; TE; thrombotic events; Cy; cyclophosphamide; Bu; busulfan; VTE; Venous Thromboembolism; ACE; Advanced Cohort Explorer; PE; pulmonary embolism; DVT; Deep Vein Thrombosis; SOS; sinusoidal obs
Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica
Keywords: آنتی ترومبین; GAG; glycosaminoglycan; LMWH; low-molecular-weight heparin; DS; dermatan sulfate; TSP; trimethylsilyl-propionic acid; GlcA; glucuronic acid; GlcNAc; N-acetyl-2-deoxy-2-amino-glucose; IdoA; iduronic acid; IdoA2S; 2-sulfated iduronic acid; Mw; molecular wei
Antithrombin III improved neutrophil extracellular traps in lung after the onset of endotoxemia
Keywords: آنتی ترومبین; Antithrombin; Anti-Inflammation; Sepsis; Lung; HMGB-1; Neutrophil extracellular traps;
Homozygous antithrombin deficiency type II causing neonatal thrombosis
Keywords: آنتی ترومبین; AT; antithrombin; VKA; vitamin K antagonists; HBS; heparin binding site; LMWH; low-molecular-weight heparin;
The M358R variant of α1-proteinase inhibitor inhibits coagulation factor VIIa
Keywords: آنتی ترومبین; FVIIa; Alpha-1 proteinase inhibitor; Antithrombin; Serpins; Heparin; Blood coagulation;
Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: Two case reports providing evidence for the role of preoperative LMWH in triggering sensitization
Keywords: آنتی ترومبین; HIT; heparin-induced thrombocytopenia; UFH; unfractionated heparin; LMWH; low molecular weight heparin; ONCAB; on-pump coronary artery bypass; OPCAB; off-pump coronary artery bypass; CPB; cardiopulmonary bypass; AT; antithrombin; ACT; activated clotting t
Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists
Keywords: آنتی ترومبین; Anticoagulation; Anti-FXa activity; Antithrombin; Factor II; Factor VIII; INR; Protein C; Thrombin generation;